-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, H96Ps8n0CVFPagCOp1zEQdZAE3AtR5hixcJuMyywr4KD+OJuJnS7WhfSNgMLXmuy FZjEa1cmftZvgbls7NliNw== 0001193125-08-085750.txt : 20080421 0001193125-08-085750.hdr.sgml : 20080421 20080421170952 ACCESSION NUMBER: 0001193125-08-085750 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20080418 ITEM INFORMATION: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20080421 DATE AS OF CHANGE: 20080421 FILER: COMPANY DATA: COMPANY CONFORMED NAME: US ONCOLOGY INC CENTRAL INDEX KEY: 0000943061 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 841213501 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-26190 FILM NUMBER: 08767515 BUSINESS ADDRESS: STREET 1: 16825 NORTHCHASE DR STREET 2: STE 1300 CITY: HOUSTON STATE: TX ZIP: 77060 BUSINESS PHONE: 2818732674 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN ONCOLOGY RESOURCES INC /DE/ DATE OF NAME CHANGE: 19950327 FILER: COMPANY DATA: COMPANY CONFORMED NAME: US Oncology Holdings, Inc. CENTRAL INDEX KEY: 0001333191 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOSPITALS [8060] IRS NUMBER: 200873619 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-126922 FILM NUMBER: 08767514 BUSINESS ADDRESS: STREET 1: 16825 NORTHCHASE DRIVE, SUITE 1300 CITY: HOUSTON STATE: TX ZIP: 77060 BUSINESS PHONE: (832) 601-8766 MAIL ADDRESS: STREET 1: 16825 NORTHCHASE DRIVE, SUITE 1300 CITY: HOUSTON STATE: TX ZIP: 77060 8-K 1 d8k.htm FORM 8-K Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of report (date of earliest event reported) – April 18, 2008

 

 

US Oncology Holdings, Inc.

US Oncology, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   333-144492   20-0873619
Delaware   0-26190   84-1213501

(State or other jurisdiction

of incorporation)

  (Commission File Number)  

(IRS Employer

Identification Number)

16825 Northchase Drive, Suite 1300

Houston, Texas 77060

(Address of principal executive offices including zip code)

(832) 601-8766

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrants under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


ITEM 5.02. Departure of Directors or Certain Officers

(b) Richard P. McCook, Executive Vice President and Chief Financial Officer of each of US Oncology and US Oncology Holdings, Inc., has notified the registrant that he will be resigning, effective May 2, 2008.

 

ITEM 9.01 Financial Statements and Exhibits.

The following exhibit is furnished as part of this Current Report on Form 8-K:

 

(c) Exhibits.

 

Exhibit 99.1   Press Release of US Oncology Holdings, Inc. dated April 18, 2008.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: April 21, 2008

 

US ONCOLOGY HOLDINGS, INC.
US ONCOLOGY, INC.
By:  

/s/ Phillip H. Watts

Name:   Phillip H. Watts
Title:   Vice President - General Counsel
EX-99.1 2 dex991.htm PRESS RELEASE Press Release

Exhibit 99.1

LOGO

 

Contact:

   Vicki Hitzhusen
   (832) 601-6070
   Vicki.Hitzhusen@usoncology.com

US Oncology Announces Resignation of Chief Financial Officer

(Houston, April 18, 2008) US Oncology announced today that its Chief Financial Officer, Rick McCook, will resign effective May 2, 2008. McCook joined US Oncology in July 2006.

“I have enjoyed my work with US Oncology and am proud of the Company’s accomplishments during my tenure,” said McCook. “However, at this time I intend to explore opportunities in a retail or manufacturing business to more fully leverage my skills and experience.”

“During his tenure at US Oncology, Rick played a key role in overseeing our financial operations infrastructure and consummating equity and debt financings for the Company,” said Bruce D. Broussard, CEO of US Oncology. “We appreciate his many contributions to US Oncology.”

After Mr. McCook’s resignation, Vicki Hitzhusen, Chief Accounting Officer of the company will serve as interim principal financial officer. The company intends to initiate a search for a new Chief Financial Officer.

About US Oncology, Inc.

US Oncology, headquartered in Houston, Texas, is one of the nation’s largest cancer treatment and research networks. US Oncology provides extensive services and support to its affiliated cancer care sites nationwide to help them expand their offering of the most advanced treatments and technologies, build integrated community-based cancer care centers, improve their therapeutic drug management programs and participate in many of the new cancer-related clinical research studies. US Oncology also provides a broad range of services to pharmaceutical manufacturers, including product distribution and informational services such as data reporting and analysis.

According to the company’s last quarterly earnings report, US Oncology is affiliated with 1,199 physicians operating in 461 locations, including 88 radiation oncology facilities in 39 states.

# # #

GRAPHIC 3 g51730image001.jpg GRAPHIC begin 644 g51730image001.jpg M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$" M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,# M`P,#`P,#`P,#_\``$0@`F0"0`P$1``(1`0,1`?_$`,8```$#!0$!`0`````` M```````'"0H"`P4&"`0!"P$!``$$`P$```````````````D"`P8(!`4'`1`` M``8!`P,"`P8#`P<-`0```0(#!`4&!P`1""$2"3$302(446$R%18*<8$C0E(7 MH;%R)#2V=_"1P='A\;(S);4V=G@Z$0`!`P(%`@0#`P@&!0T````!$0(#``0A M,1(%!D$'46$B$W&!")&A,K'!T4+2(Q06X?%2;_Y>T:\3 M,1V](DQ)'4<9S<0Z7NNH^+%)%>`I(R:?<=C(O'9"NWA$P$Y6Q2%[BF-MK='Z M6NT%WNEQ)SO>HM-E&"VSU8*2U'/`(7`.])PQ5*CS^LGO;'MMDSMMQR1K[Q[V MR7A&(:6/:YK>@58PHQZ+7=/B?Y=J/:$%:UU%HS M!6N6TY1!-P"O#5:[UMR/]5;.C4BO_`,3K_I\*O:5]HTI1I2C2E&E*-*4:4HTI M1I2C2E&E*-*4:4JR=7M#\.XB'0`,'4?B&X[`&VC5=DB]?*J@!I+B4`S\JY)Y MI\IJQQ*P7:5 MF7BKQVHV]WO4*W)[@)(@<3&(@4I?AJ8_:=GM>.<>M^/;6T1V-LUK6-'0!%'F MHP6H'.3[WN7(=WN=^OY"_<+N4O>XDDGP&:X?EKK'@#R?E.+7)NB7SZR4+2YI MVA3LB0L8LS13FJQ-+%;(`NB]508BE`2BR;TAS&!1)(BH`;8PZ\Q[W\!V_GG; MJ\'MM&^6I+X3IU.](<0T(A"H!@N>1RKU[Z=.Y%SVV[B6E\V5S-LNI6QSLU:6 MD%P!<3DN)S&?A4\M@\1=M6[IL=)9LZ3*X0625*HDHDN'NI*(J$$Q%4E$S`8I MBB)1`>FHC'VQMGN@<"'L<00H:M-<#'K=@Y42OKI2V?V2/21@?S)_35[7VKM& ME*-*4:4HTI1I2C2E&E*-*4:4HTI0.E/AG6I7"UUVD5B8MMMFHRO5NOL5I*;F MYAVW81L:P;@!EW3IVZ,F@DF0/3<0[C"!0ZB&J[;;[O=KF/;=K:YU]<.#6AH) M<5*(!CB5KJ]TWFSV#;9=WW-X996T;G2.)`"-"DXIX9=:@\>0OFM8>9.:I"42 M>NF^(*2]DHG%E:$WMI?EY5#M'%LD6Y3&`9JR)D`^XF-[3;VR%[1[MY:^Q':; M:^V/%HKB]8U_(KF-KY7YD'HT'`H`GS4U";]1?>O=>Z/*IF6VW!Q#?OQ_156P M&[@$H&3/_3,0VP@9,XAWE$H@/<'M=PB']T!'5$T$<$C9)T=;N"$>.7]-ANL$="B_:M2\/#/S1_QHQ`/'^]S/OY1PU'HMX)5ZH4'-KQF3M;0K\# M*`*B[ZMJ%!BZ$-Q]H$51_'J,+ZG^U,W!^1MY5M[?_)]R:7HW)DA<00?[^DN^ M*^-2Y_1]WABYOQ'^4][>N^V3]#%(5T6D.4>*%WV8=*>\`1,!/0WIU-L`B'3K M_$0UK"/;+0\X+^6MS&@$N;(/4TUZ-?:^T:4HTI1I2C2E&E*-*4:4HTI1I2C2 ME?!]!^/0=?"J%,Z5&3\Z'+-JY_3W$JI2YECN.XVY``VZ1P!,<=6MRGY`)YU M'%];G=FV+[;MCM,FK.2[(.2%J##J-+LUJ-N(B(CW%[1[CCMW"/0YS*`(@)2] MIC"<1$`$0#?8-;\N.I).C@OVY_?4:$^C4L2^QDWY8?FKYJFK%&E*7#CAG"T< M<,T4#,]24KGC6ZM='>P2D(?`9?$$8@]5J>CB'++'FG'[3D>TO: M^SNX0]P!72XM!TGP()0TKFNJK)Z-*4:4HTI1I2C2E&E*-*4:4HTI5)C=NP?$ M?33`8G*OBXZ1^)%I&\\9GK.!L27K*UO>,H^(J%??28'?N2MT'<@5,R45%D,( M@=1W*/S$123(`F.8VP=1UWO&-AO.3\AM^/[>US[N:1H1N)#5]3O]5JGY5B'- M.6V/#>)77)]R+6001N0$HKD1H7S<@J`;G7+5@SGE:_95L[HRDM=+1(3HH(KR M:DWZ2X*@*?DHU?K[[0\:J`0`!^4HCNFU_$.0'MWR"75M%[* MUL+GN/[N1QT-#0K7'\8Z!*N"U.JN`D M/F,C#QR9O=W_`**Z+M,Q3E^4-Y!_I8[7LV>%_.][@<+^16P->T@AI`!<&N:' M`E7`Y@@!*BZ^LKO')R#=(^W&Q7#/\KB1TSF/!87C44+FDMPP3SJ/_P!=MMNF MXF````*`CZB!0```1^.VMU*C_P!0.*U\^WT_"(]1`!V#X^H>FK%Q*R&/6`3. MJ``*?L%?"6E`20%Z?U4L6$<"95Y$VUU2,259W:+#'UN?M+U%,4T&K6*@6J[U M8[IZL`H).'Q@*W9IB('<+;$+UUC7+.9<&`IF M`"Y2<@`2%:6D.#AX@A01YA:PN>*2W>Z*=I9*TH0X%I!\""`1\P#XU07UW^'H/^7_I MU<$K86.F;B]-*#'SJW)*S^&]@!9->I?)$JZV6=(KHJL5U6SINLDX;.$!%-=J MY15(JW=)*)B10B[=8A3$.`@8I@W`0'KKBLVY]U9OM=RTOL)@6O:2"K7!'8+X M&N18W4EE>P[C`7C<(9&/C(_ML(/4&YL+P@99QH5&A99BU MW""C]O88ELFDSF3%056(JTLD8FF[*J0PD,H8X>H"&HA^]_;Z?M_SRXMX`3L% MY(Z6!P'I+7%=#?$LU(1F,*G)^GKN;;]R.WUO<3O;_GUG$V*=I(U`A6ASAF`[ M3F11(=3Q^%SE'W"O=6M+&AIQ(%5ZO5]HTI1I2C2E& ME*-*4:4JR*@=HCZ]`'IMOU';XB'IJAOH8'GK7UAU:2.M-=>2?G30^+6-).KI M1[.X93MA&+.O4IVHJ5@=LJX0=NY6>.PE(V79Q9&#=8$54.[N=$*0VP"._N_9 M;M-OG<7D<,UJ[V]J@>#(\#$8X(H(7`X'!*UH^H;OOLW;/CUQM3M@M&.DE>X-`;B5/E^2ILOC#X-M^(6&#R=K*FYS M/E%".F,@.>T@EKS=N'U4+2H\X;E^EA?=,=Z'+W>P MG\OVC],87!S@3Z_BI0?\E#UJ:[Z:.SEOVGX7%-=`C?MQCUSJ,6C2/08`Y"/\J5Q@FABS.TC(6**.R9_3L:Y>DP(K;ZV;VMTTR2*P#)-0 M```Q%5"E#Y!UN+],7=&WY3P[^5[Q_P#\AVTB)A<0KH_4`1U1H:UI/B/.M$/K M&[2-X-SMO*]MC)X_O)=(H'I9(=+B"<0"LA3+"FC1*8HB!@V$!V$-P'K_`!`1 M`?Y=-;.0-#'/C_6#@OF2`?SUIZ`T-#1F,_\`3X5ZV!HXCQNK)IN19)^Z+HK4 MK8RR@@BY%N!".`]DJ0K^U[V^YCD[MMAU?+5P5`>OAXFK\+@V1I!0@A#X%13Y M?C6Y"P..9AKEU(E5QW5:?`OJ/RA.UC%6=>DL>2,P9UB2[MXN`+)N"76N659Y M%/WKM-)LJS6*)U0V(&M*^_\`P.^WD.VMTKY[F]D<_:D)%<%QEDPC]G* MQC.3C7C>0CI%!%ZP?,W!';-XS=(IK-G31RD)DEVZZ1P,0Q1$I@'<-1^/CN+> M5]K=1F.>)Q800A49J.A51\JE+M;FTO+2*ZL96S6DD8+O6L>5UY8[;)H1D0W78,OJ%2JJ^Z\DG:3*.:)(M MTEUUW#MVN4A2ID,8=_3H.N7M6W7.^W+=KL&EUVN(ZA,2?!/C73;QO=IQO;3N M6XN#;9CD!\1@B_/PJ%5Y!,^5CE!F:YW.97AZ>\I$3+5RA-:NREK&EDT$KFJW M0E9"SR#>+<0+`\2HNJD"KO0`$P?'[];,2/=-""XZ).NGJ?G6K@\,W$- M;-.<$LY6Z),KC3"[I"0C_K$C?26/)&RWY0U:B5&#+AB*X));S#,759F13(+FL6Y MH10U?G&:G;W)*-'9NU0"B'NH'.F/XM9MV_YO?\!Y5;U1J:?C MGAD0$P4'SGN=V\V_N3PFYXUNC5DOV=? M^;_/Z:[MC=+P)0I!Q'CY5CX$2ZE)C^2IY=%IP/AGGC'U$O\`*6#+4;^IH$*E M!0=RK0+5AA5KGBBGQX'<5M_`2YXU*4%O<=+$4[@.)M>&=U.$\A MW79G1<;+?<%Q[L$KM1D@F=JPC+5#8U>[67`H$"M"KL'VP^.,Q!DT2L36'.!U:6-`+$ZJIJ4-X]TBN55-)H0#I@8!$8\.[.REFZ_P"? M6,D<[G^B]T8-BO&$LD9&W!VG2(W*5Q+LR52^6 MQ=BV5[FES=1D]YH"C!HP\7)_=,!B%$"AW&V^([!OZ=!_$`?RUY&T$+[A"XHB MY>:UL.I+T:TE@&)PS_+5_7VOM&E*-*4:4KX(@'J(!_$=M.J=:(:I$Y``VYR@ M!0^;F^OFH:M((UCI7W23D"E1G_*+SPM\OE2V\<,&62(3K-+Q[,- M2%X M0R!SE8"H&I&M`"KCEC4=AXRM]D1>70L3*2C>1FG"+F3CXL5F:DXLV5FG;46K M%'I[#(WOB5,@``;&^(#K>>[W"QV6&.UNI((@6+&QSFMPE7;*+E?SN/;JE3;R81[J,^I MV23%4OT#O_64!;+B=$>[\0I]P=!#5NQNY+_U:2&_;]XPKA7D$=J"6$&09^(- M*-A7#EZSYDVMXLQQ#.YFR61TJB@DV2$X1\>U3%Q)R[D^Y$DF\8R*94PG,4IC M`4HC\P:ZSE/.-L[?[)=;_O,D7LPL(C:YP!X/ M)K7CFUQR27$S@7EC2_2Q5*H7$&-8^*/7,>1\?# M3D]%F:`I,7\[9-U;32:;(ITPF2+K$.Y."J@`H?V]P$@@$0'<'?=TY/R>\Y#N MSG%US,7QL*JR-3I:AQ1$TX!1CCG4Z':/CNU<1XE;\=V1L;66L;6S/:B22D*X MJ,'%I):<3I(0XK759@V(`?,'IML0PCL!N@"'4?0-83H,DPG!1`<#YJOY:],D MCUQF,%#FOPQ_-7PQ1VW`IC=PB82"7;<=]P#<>A1`WH/PVU1+,QDC(-!1QS`4 M#+$X5]:Y\@;(#I09'K42SS)<4WU#R0TRY#1@NF]J:24M,23*,,R;?E[-<3J- M%A(NX37D*TB(F4$H)@+)=(2E'VU!"2;Z7>Y;-QVW^7;B1HEMG!K6.>KG-TKJ M"XEI)\T/6HJOJ][4S[=OIY+#&]\=S$7E[6DM:0[3I<0H!0`XD8&F+#$$%%.\ MO:)1./:(>@@([$';8IA#T';H(^FMO=8GO21C&,ST^W*M"%:&,8"K2X*AQ3!? MA\ZI,('W[^ST3]FXE[@[0'H(";L`?3<-_0>F^OL5LQ@E;-(3`%>`"JXY# MQ.-<@.C0N;J+51H+Q]^&6%2/?'+R/-F=FC4H-VE7,1$_PIHCE69D:KDI MO6:^M'&_-GSF<$%':3Q=RPA\NP[U>: MYG$:76SWD-:7`-]##H:T.TYKQVTY'8M(MYXVN/J`1R`H0F.)P\:6C765E=&E*-*4:4JPO_`&!^ MP=_7KT$!V`!Z#OKXK]8:T8$''P*85;E8YS0YFHN:X%!U'45Q!S_SA!81XT9, MDY._M,=V&U03^I4266276?O+1)Q[E9*/AV[5N\54DW,SW$=QY3SRRB@LS?6=N[7<,P`+`X8XHH!+<%4^!%>.=_.967"^W%]/_F+ M=OWBYC#;9Q.+']<`#F&NQZ$BH2$?'S^9L@(5",[J*S,H"JF<'294>+?5Y)`%O;0%ZH*O>*@=`UBNX[XWDF\3/ M.W1EIMX5_=:FE7/<`/4YK@$#B6M(72H6LLL>?WG!]EDV';(&MO)-7OO=^L2N MG2JX`%RH`JICTYJ4/)3\JF8$W'WA3)0^)9 M/,EU3L5=E_4-8]HZ:JB\BU+5(ID>*J%'O%ND5,=BF' M4>WU0]T]ON^2LV';RV6TVUY83F/>_#J(ZHBA>I7I4HOT@=H+K;N,RHZU"GN9[N9T]PXND<54E<#D/@`@'D*WVL;:TLX!;6+`RW M;D1^L?UG'S+E6MAU9KF4:4I#^0>((7-V-+)199G&.%Y&*D"0[F49HOD&,HLT M7;HG.@L':=NY(J9%4H&+W)J#]VLBXORK^6-KG(?$`_GJ!;F7%; M[AG*+[CVYQF.>&1P"X*`7##XI26ZRRL-I4L/9:NV$KS&9"H$^]KD]&(OH]P_ MC?8%XO`S*(,)V*("Z*Z?MRC`YDA,)!,F.QR]0UC?*>.;9RK:9MJW.!LMMH#W M$_VFN!@R(/IF#7#\^593P_E>[\/WVWW;:)GQ3M>YI1$T2,=',J@CU1.W?[=@'KT'UUK-6Z=5Z4HTI1I2O$]'8I/XF]2B8O78-S"`AV@`CZZI>)BT MLA<&N=@I!.>&"=:)(#[C%TMQ(U!J@8YGX5%&\D%M5S'ES.J5@HZ2L%CZ$HDF MG=W>7:S-OL>00/'U>B'N,ZQ`RC*.74L$VF[-+LG1G3P#F*)Q`$TRDW^[$[1# MQC;MNO67$L.Z/=(6AMO,ULQQP*">VX+@J`COME>;4V>$PSOD?;G3Z7!CFC25("MR< M4553]5*TOM-^;:F"XCCA_B/:]K4A5"HU9_B1QQ^&%;>\JM1_-)BO2ESEF]GC M2-#C.3K9-1HY,SJCJ3E8M90C]RDLP`U7!>W4,T-FV M%KK4!V0/IQ"(5 M^36,:1FB=3KU*F)QLX%RH]=-#RTS&N4)",K+=T@DJW:EL!VOMK++F232:]X@ M?N$`'"^\F]\CV;@4^\\4@=)NK06D%NL-800YP:"TDM&(1<4P.-9]V+X]PODO M`+"QD-&-$&$7% MQ2D>TCV#)L'8V:L6K8R;=NW01'M*0A0`"AJ(>X9NEQQ`!D$U9(*Q5AR31Z

R=DN-7A(V,:B M^DGLK.1S9%DS!7VOJ7)S.`]IOWE,', MO-,ZZF3N9V_AB$TF[V18X@!'MQ)P\3UK8VN=L522Z[:'O5:F5F[]"-53B95B M^,5XNV(Z%!/VG78Z4;H*D.L"(G%(IP[MM]6'<6Y1&SW)=NNFL122QP0>)PP^ M=7?_`+%X020W=+,GRD;]V->AQF3%H-9Z1/D2DI1E6;E<61^>S0_TL*ALHH"L MBI]69-%,"ICL;?;O`2_B`0T9QKDAE9;/V^[$\OX&^V]7?W1IQ_1C5R7G?"WV MKKAF[V+/;=BLK/#^]C\NN%1A_-!9N)N33XRR;@[(./+/D]26DX*[(452',P0344%0YR*B76\'TK6?--FFNMJW^TO(MJTL=&7 MAS=+D<'!H(_"4:2B5'5]:-[VSY/_``N]<:O+>7D#%$@B((<%:079J[%PSPZT MPQK=VH\JN$,<"F`@[#N0X=`W`2"(_BV[NT?B'W:I:7/D?;R$BV+&N)&>IK]0 M"^"M'2KC'!KFEP].K/KB$2G;/%)R6T5_FS*FG'E9AWDN5VFS;R!G3AFD8SAVS8KN6K91V8 M!.()',GN(]HB&HT]PMQ:7CX&N_=-<6@D%2X'Q^U14M^U7\FX64-P]H;+(T.< M%!0')$^29UOZ1A,7OWF+_GU\!!RKXXAH5V`IJ/R8Y]C^VNZ M.-G!=.6+"2TXMU'`D88>=:R_4=WHL.W?';G9[&>W?R&6WD#HA M+IFB#F_NW:0"X:U=I.'X2E0V7T@TF6@&#\\6LB\JY!!LP."L*C7W3D9!G&LF M1A._<+!.OE3E`1,``8-PWW'4HME8Q;3*V-[8Q:0-#6$Q-`=EEXU#AVVYH4I6EKLK4I!`2%;V M271*00#8!*";LH%$`Z=-8S_+'&_^&67^[9^Q7>?SERFGW;L)0=RTD^`!*?N+\KAPHET,(B&X#U'7,L]GVJTE`M+*TB:_[YN4?M75] MAO[-78][O6Q.B?/<.#O%[OTUXP`@`'84I!`-A[2@7?H(==@Z[;CKM(#=2:GL M_AX6IB$`)'4#TC$Y5U8F>'N=,3(2#F247KC1JFK%5$-VC]PAL.J3BK?$9U4X M`Q)U#EJHO]W\6_:!0]TR?X3]Y"]X#N0`/UZ>@]=)?X>2U%I=,:^V!4AP!"=0 M5Z>-7&7=S!*VXMY'Q2L1'-)#@G4(A6I9/BTY/X;E*[67.2^2S*7SY=*?'UBQ M5Z[2$5!O77Z>L3R-I=>;(]J#9S(UZ,<^VT4*I[\@@_$3%,=$1",WOMVVY):; MW=3;%L,S>-0.,K9XHG&,!P#GES@,%>XX=$PPJ7'Z;^[/$;C9;.WY#R.$\@GC M$0@N)@)'%N#0UKG$E&L'A3\:`[D'IVAW"``(;#TV]?OWUJPUXD&H(O5/'K6Z M\3#&"Q/2'%/,>-7M55=KFGE3R0IW%7"5PS+=4W+YA7TV[.'A&0F*^LMDDE`; MPL"T.":A4#R#G<#*G`")I$.<1Z:RO@?"=Q[A"#;6C4:W^V]Z!H'S=]QJ!YG#+]QS]EBZY8OCSZFS MWB>7EG:*2RPL(EMN#9A$Q2!]D4F,6P3*@0P`!=@$X]3#J7KAG%MM[><;M-AV MUC=%JW3*],"]H:'/_P!8@G*H*^X'.]T[B\GON7[P]Q=/+J:SPC+G.:SQ](*` M+Y"ETXY8%W7; MUUW>P;[NMY#MFVYK*X8@X8-`>XJA.`KL_D3R+X9XEXY3F$.%,[/S62;98BL; MIEI>F&A7\AC@"R*4M!1MHD6K:41;.2.4V("5,'"[0ZA5%!`V^O'NW_"N[/*> M:Q\B[HM,6R6S=4<1>TM,BJPZ6EP<6G(N.!0MQQKVKN%S/LKPSMM)Q3M)(9]Y MN#H=XH%`1V*4@@!=B?A3W`?0.FMPO M;?&T#2&P)Z?-,ZTFFD*"`H="G5U)=B5/5#5&OE6*-*4:4HTHJ8U]V`!V,($` M-Q$3;_`-]B@`")C;!T`.HZ^*MQ\1.P\LX3:![JK@L7(-Y$J+8IG+`#*J':@7N]Y/ ML$=^X!#?73;]'=;SM=[MK8F:)XRQOW>?E7?[-NL.P;O9[HTN$MM*'_+']/SR MK]!CC)FNL\@L'8^RO5'[-]&6B!8++`P,JHC'2J35%*6AE!6,=8KF'?@=NL!A M,)54S!W&``,,,G->-7O$N27.QW[#'-$\H"BEI)TNPPQ']*'"I^NW/,-NYSPZ MRY#MC]<4D30[/"0-!<,?!12^ZQ6LXIGCRS\;\@YOPA8+2.9D:-BW#M5F\B2E M#1K[B1&\V6%:G],`%-9'KLJ94/Z@]QC)&W%/LVV*40ZAMJ5 M^)GO0Z/2^)[&DM_%FOXCU^8J&AH=;-+2YOOAY!](":4TIX=:S5ALT_;9=Q8+ M/*/9^:=(M&ZTG**BY=&;Q[)*.9(%4,``1)JQ1(D0I0``*&K=AM5IM1U;;;QP M.Q_`S3GBOP'7V)MU<6[(YA*6QY*OW^-=4YC$#6B-@:$"(/ZZMBH4RFQNT M!`O<8A>AA3+\HB`=>H"(:KMX[NXE>UP(:W%#D@S0=/.JBTB$`(@*+YG'&KAD M5RE(8S=0@''Y.G_G=QMB%1,;8JFX]/EW'?[]<"'<[6>*2:/\,90X]?T8USI] MLN;::."5KC)*`6@`XKX4M#/C=GV23*JPPUDI5`Y'1B.0J4D5#_TZ.+)2``JN MFBD8Z+(P+=H&$13,7;YC`76-.YWQ:"21EYNEA&Z+\0,L:XD@(KAF00,*RQG; MGFM4G+&2>H&;G.V8.D7*:I5!*(=H@7U-0U-&+1^KXIX^%8 ME:A75JI(IN:?:&YX<)(\DDO!2**C)."!`T\=T"S=,42PI%0%R`@!D>\!-L&N M7'OFPRO;&S<;0EQ`'J9B7%!^OU.7CTKC3<1Y)"_V)-ONA*8W/_`_`-!)_5\` M?A5C])695G&RJ,#-DC9@SHL#*'8.D&$XXCD&[AZW@EUDD/SIPDFY+_3:BH;? MJ&X`.CM]V833VL=U";BV_P`1'-*(N87!4*+5%IQCD`CCO/X280/_``DM=ZLL ML$\^N=*3*TI:,J=4GLH2%F:(R];D&^-XRO1-8E'#]@W0M( MK*`MWMUED4@$1'IL'1MY,+V0C9FQR0!Z22.<0UCL%'X2"=*$8@="1G637'%3 M!`)-[]R.\>W]S$&HYP\2I7-1E2=IUUR^A2JQM>LIY:*=&2M3IW](G"L`=I_4 M1#=N446SI%PY9;K']XXF$.I"=NNV;N;&/:'W,+V.<`2UH(:%Q)(<<`,>F58V M[9I?<_[M,R./!P<2"YV0`5N!)P`QSKY2ZU+7N9:TZG5J3N=LLBS1C76%?^J? MR"+H[I,55ACF"#@7B"K01#N-VE3#Y]_AJOW4'M<"`#T*`H>N/0 M@UP+BP;9$Q7Q='=M*&,A"?,=4.61R-+YB/BOF_,_U04#'T[//4XYE*Q;=!!H M#>2*NUDI4K=,[QTD9VNZB81RLB@F4SA7=,`3]LX*:PKE?1<%R3J16><4[507;&'8GPS8- M=^[O\`/7D->^5B7S=H]:KLWK1%VU[[K7`A[$&DCJ<0?L%6)X(9H7121LDMGA',>%4 M',(5'VFN`K_XN>"V2IE>?GL"P$5).C**+.*<_FZ:FZ6N[)WR[H\>8ZUV[<2ZVTM`,H;([!<`7-)P^/6O"=Z^F3LGR6 M[-]N6R@3N))#99HFJXJ4$709TESOPR\"%45F9<>VID*SALY!9OD"PF> MD!F!P^E2<.W+I5-DI]1NH4.HB(;B'37?CZDN[_\`Q&+_`'3/V*ZC_P#(78-/ M_1@G_B;KY_\`/>0K7)3PB\&)*0_1OV8W&4SNM[B)W@)7#Y(I_+6<<> M&?ADI5X:FC`W(\%%WA[>53#8683Z+!)9`/<4 M.)E!W#;KG_4AW3ENWW<]XLKH1&-(`8`I<7"-`W45`+D5`!EA7+=])/:86\=I M;6[F11R:B7.)<[``*Y24'AAFM+5,^.WCK8G\&YFZI%S<;58E[5:S79>OQ+B$ MKM/D46C=>N139FBQ43*DBT'V'JIE7[SW,-Q):`N@9I;AT"IUZ+G\Z5@.+./D:-#8T MB$G$32HJ9?S+V'(U8RJLX[D7Z,PJHK)6!)[(L`3F$4URBV5()03`F_:&VL3D MYCO5Y>W%_N#(WW5P$)#Y`T?BS`(7%RX@^59W!V[VRRLX;"QG>RUC=KQCB)+@ MAS+2A](&"5NCG`=!F5+!(VN%;VV;LT9%Q$Y*SC%BJ>0CX%TJ\A&SB-;D0C5D M8QP8#$#VP,H!0`XF#5F/DN\QV\=K'*(K>(N+6QN>BO*N*NQ4G\_6KQX'L%\^ M:XW"+W;B=["XR-:O[MGMM`#<$0+CY436#*M/2L-(OXZ"41C8.VQ2S+]+PYB2 M#R\,5&-EE7IA(5)4LLW.(.6ATSH.##\^^P"%,7(=U@0QW$P1S"/6[`QD%B%5 M&DA00B=*YEWP;C%Y/[\EK`OM/8F@9/#FN7#'!U8)SQBQ@Y'$2WZ;B6K[":ZR MM&>L8"$:IQB3J)>1+IJRBD6I8R)151=[]S5,B@&3+L8`WWYUKS#?X)+QTES) M(+W_`!=3W*[$G%WXCFF)Q"@YUU-SVRXA=0V<#;2*)EAIT(T`/TAH5//2N*9U MHSS@_@N6L!+).U)G.R49"2%=IHS$=%R*5$C)1@LS>)097+97ZHQU7*RP*N_? M5`RHEW[``H=@WN5RNVA-C:7,L=N]^MQ8=*N"!220C@00A!4! M2@.1Q"&K&\]BNVN]/$UY8CW7.:\^WZ4.K5GJE>IC M>H(6AC)0SV8IB3"IVIK6I1\E(R->AK/7F,?*QD/)/$>Y1,BH*`!Q`IRAMMU- MWW#Y;=W3;Z>=\LL1!#)#JB<0$#M!)!(Z%P5<!^PITQI.,A^-;B7E.0QH\N^.7<)@*QU3G56V^"]'!7*\X^">%=1XUPIC3 M$5;KU1Q[3HJN0-5;&9P+=JF*CABV4!=+L"07%1ZN"3=P=(GN',)$A[0$`#6" M;OOV];]=27F[W#Y9Y"2Y24)PZ9!4&0Z5ZCL/&MAXO:LLMBM8X(&H,`%">:DT MJ8I`("!B[E'X#ZC\.H^IOYZZ=CI6X-3[37>@:'F0(I\`/T5=+OL.^_KTW^SI MMJK'JB^5?&DE25SJK2JJB$/N!FK1BVBJGC3'TY=)_P#6 M^1;9:G1FK-_+O1:LF:*CE1HL`IE*I777(OD+ROX36[C#"RC6%Y38NY$\CL4\ M>IW*LI%Q6/+S@J:R18D6#:PVN"I[,E9N]4GF#-PT:+MD8A=A+BW*M]0FL4`4 MKN'EAR.J^/ M64U+05,F_Q,>59ASX7Y`8& MRM6X/&/,_A[D&P8TY`8X@G[MW5YH:_8I.J(9.QO^:&&73IT[*Q*B:C-R95>+ M<&(D=50JR1Q4IYG2E&E*-*4:4K4KFVG5*O8S5J9:0,^$4]5B)EY#A.-HYXBB M"R"SJ(.^CR2:)3I#NF*R6X#L!@'KI2HW/[=KRZE*I.;L*8 MVV_:`CMN4-]OANQUZ)F;(JNA6XB4G(Z/EK"LV M*!G*4)&.UT7DHHW`Q>\J!%#%`?F`!Z:4K94S^X7N`-@W$`^_;IO_``$?3[M* M57I2OSR_(I__`&.P9]R?BOC;Y.L&XTEZ1:,FX^0B MVLVBCIQ'KL?I"`*OL*%*8@J4X-^ M]+R99*]X_N.=`AGCA&M90Y--U+05`P%:R2%*H%AFX5HX,!=W3?\`-'8.$P`> MP5$`-U$I=E*?P\*[%NQ\2_CQ;-R%32'B=A]QVD#M`JKZJLGKC;;T-[[@VX_; MI2H5?$B^9,QI^[6YH0^(;!%5=[>LE6:D)#\<\$7?#4S6BP.1"X M\N=LI<-&3-;GW+*!&GO\AI2=DM4U-PQE5G*K]NTCH],1*W#,H;+BMZ1DFN.HRIP<[)RZL5<;):8L M\5[/UBC/O435_D7E:O1M(XE05&DW ML/#8IL4[:$V2=PSJM9$9IID)2EU9:0(_1BPBSR2J+4&`IB=0%*[-G_,'*YX\ MAW'GQJ\4&L/4K[?,(M.1'(3*U^@5K.OAFI2N.V&1('&==I24C$,I;)SZ,F6` MOG+]P#"-([(`-W*@F(12MDPAY3I]IY+N0/B-Y/\`Z6=Y?J]$;9&X_9EJ$2YJ M\1FBE2M`:W20K-HISN1ED*WD:M,':X][!VHQDT6"QTTFYP!(5*C#?M@.5N+^ M#W'KS,\JR;5TNWG&[UVFHB@+=!/2E=N^)'R[2/DLY;^.;G3;L78_RI@N/ MO[3'D7CO%S2#8WF4HTNO!6"18K'BOY(L=^-W.ME/7H[)7CZXLOL6N["^]JHFS]25XGQ%1: MYSGRORZQ7BS%$ICZN1$#>K]7)XTH\R,-E9P39HI:8.EQ3,DRZ?/"J?E96X#[ MQ"*F(92NZ/W$'CGN/D`\95@Q]BF."Q9OP#)U_,^,H-KN+NX/:;!/XFVTR*[S M)@:2LE2D7!F)!$!5>HH$W`#[Z4I=/`?E6OW[Q#<+E4Y!%"4Q=B9/#V0HMXH9 MO(TFY8A?R%0L5?M35R5%>!EHQ*+26609^K8@AI&R6W''(+BCFUU5H1!9[-62HX^5S(-K8QT:U*=P M_7BX:74D_9(4RBGT(E(4Q^THJ5/1\'DYAR\^#O@^]OI\?6#'M-PNVCKF2ZM8 M*7K,!.4"V6%I+C.-IU!U',I""?,BJ;K%*=$P@3=2E+MO'J^\AOW>]ERWCYLZ>8WXC8LQ_=/*\'$462 MDDA^E1L-DD;.W`K,3"M].FJH8H%3.(*5'N\??&K)?*OQ0><['^((^2L%YJ>3 M^,N8VU0AT%WZ!AZEZ#I2FX M\!,.,?`;`/B,Q;Y!'7)W`D;,GOHAAF7+4C'Q_&Z=HE;; MD*2)L%\3.<_(!RKY.8(YB0O)+GQR MA@VKRT,7%"MV(8^MXHJD;66"M0Q+1[DT35DV;-"L1ZTH[.^?R*GL%.<$DP-N MI397GVXGYUXW>8WQ\>0+AFF:`R-RLO%?XXS4HV8?5L$W$@NT M+-B:Q+>Z4QMC%@CFZ[&TI4W?&E`A,68\HF-:T@*3`DO3+_ M`%B)M%=?&(`E074C99NZ23=M>X1263[%4C#N0Q>FREO&/P%XI68ESX]\ M5L2XSMC?W/RRP1<(XE).`]XIDU_TNXL3Z8-5??2,)%/RWZ7O*(@;L7V]ID*F8TAVE^C8-6LP]UG'T_=+5!5M8$@7KU=L M%UF+#+5N$=%1("[9@LV26`I>X!VTI71)4>T"%[]BDVZ`4`$VP"'4=Q[0#?IM ML(;;;Z4KEBU<'N*=RF[A8)K"U63D,B*@XR(2`7GJC%Y#="D=NL\O\#4IF#@; ML[=M3BDLK*-G2BZ>Q5#'*`%!2ED5P]C!7'">("T*HM\6HPZ5>;X\95^-CZ:V M@FX$!M#-:_'H-8YI%H@F``BF0I=@VTI2)4+@5PMQ4WLS3&'%S!N.6MSB%8&V M-:-CFMU1M98=8SIAW8L M#\<<+X;GG[1PQD)7&>.ZU2W4BU*YE@]P3"<=]*4JN4\#8BS;'P<;EC']7O:-6E4)ZJ.9R,*>7JDZ@7VRS55G M6JC6:K,H"7R`NP<-U`+\N_;TTI6$JO&#`-(I5JQS5,34>#I=\?O96^P;.#0[ M;W,2*J:KZ9NT@L965MLTZ,B3O>2"[AR(%`ON=H`4%*UG$/"GB1Q_GG=HP7QO MPOAZQOT%6S^:QGCVO4F0D4%BB14DFXKS-@>2$P"/5<3B&X_$1W4K'CP8XBC8 MR6D>/>+32:=O-D(C,]90-52Y!,J#@+Y^AA5_18W)-T'O$E!8?7D7'W2J@?YM M*4USRZX?\7O(_P"12Q<>>=N&J[:J5ACC=0,@<6BJ+S%5LF1GUWMUPC\\RC:[ M5UY&3,XRQT[@:^S/`E7419C)_6BCW./<*I7'D=XD_'_PR\H/"V]<%Z'/8\ON M"H;.V8^5,36;E9KU#U[!2.)9ZM5DML:S$K,*Q%HNE^FD&T*R(HFZD6[9ZH*( MI("H"E=`\,_)[@7SCY#P0ZPMC2WUZO\`%;.]YS7DV.R4PAS3%>IJ!^`YE*D;$$#%*(>@E`0W#;H(`/IL&VE M*JTI1I2C2E&E*-*4:4HTI1I2C2E&E*-*4:4HTI1I2F5O,1_L?%K_`(IV3_=Y LMI2M7\+?_P`&Y6_\62?^S2>E*Y/_`&VG^P>0S_\`6\C_`."4TI4H'2E?_]D_ ` end -----END PRIVACY-ENHANCED MESSAGE-----